Joincare Pharmaceutical Group Industry Co Ltd (600380) — Cash Flow-to-Debt Ratio
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥1.09 Billion could theoretically repay 0% of its total liabilities (CN¥11.93 Billion) in one year. See 600380 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Joincare Pharmaceutical Group Industry Co Ltd Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Also explore Joincare Pharmaceutical Group Industry C equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year debt coverage analysis for Joincare Pharmaceutical Group Industry Co Ltd. For market capitalisation and broader financial context, see Joincare Pharmaceutical Group Industry C market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.35x | CN¥3.89 Billion | CN¥11.05 Billion | ▲ +19.3% |
| 2024 | 0.30x | CN¥3.64 Billion | CN¥12.32 Billion | ▲ +3.1% |
| 2023 | 0.29x | CN¥3.93 Billion | CN¥13.72 Billion | ▼ -1.3% |
| 2022 | 0.29x | CN¥3.98 Billion | CN¥13.71 Billion | ▲ +23.7% |
| 2021 | 0.23x | CN¥2.56 Billion | CN¥10.92 Billion | ▼ -30.8% |
| 2020 | 0.34x | CN¥3.02 Billion | CN¥8.92 Billion | ▲ +18.1% |
| 2019 | 0.29x | CN¥2.31 Billion | CN¥8.05 Billion | ▲ +36.7% |
| 2018 | 0.21x | CN¥1.83 Billion | CN¥8.69 Billion | ▼ -3.5% |
| 2017 | 0.22x | CN¥1.87 Billion | CN¥8.59 Billion | ▼ -10.8% |
| 2016 | 0.24x | CN¥1.64 Billion | CN¥6.74 Billion | ▲ +25.3% |
| 2015 | 0.19x | CN¥1.26 Billion | CN¥6.49 Billion | ▲ +10.3% |
| 2014 | 0.18x | CN¥979.46 Million | CN¥5.54 Billion | ▲ +31.3% |
| 2013 | 0.13x | CN¥635.52 Million | CN¥4.72 Billion | ▼ -23.7% |
| 2012 | 0.18x | CN¥734.36 Million | CN¥4.16 Billion | ▼ -9.0% |
| 2011 | 0.19x | CN¥650.36 Million | CN¥3.35 Billion | ▼ -68.6% |
| 2010 | 0.62x | CN¥1.11 Billion | CN¥1.79 Billion | ▲ +77.7% |
| 2009 | 0.35x | CN¥605.66 Million | CN¥1.74 Billion | ▲ +49.5% |
| 2008 | 0.23x | CN¥455.01 Million | CN¥1.96 Billion | ▲ +5.2% |
| 2007 | 0.22x | CN¥429.26 Million | CN¥1.94 Billion | ▲ +51.0% |
| 2006 | 0.15x | CN¥272.50 Million | CN¥1.86 Billion | ▼ -45.1% |
| 2005 | 0.27x | CN¥363.13 Million | CN¥1.36 Billion | ▲ +58.8% |
| 2004 | 0.17x | CN¥241.71 Million | CN¥1.44 Billion | ▲ +34.7% |
| 2003 | 0.12x | CN¥172.25 Million | CN¥1.38 Billion | ▼ -73.0% |
| 2002 | 0.46x | CN¥236.13 Million | CN¥511.40 Million | ▼ -28.6% |
| 2001 | 0.65x | CN¥223.79 Million | CN¥346.20 Million | ▲ +89.0% |
| 2000 | 0.34x | CN¥171.61 Million | CN¥501.77 Million | ▲ +53.3% |
| 1999 | 0.22x | CN¥109.82 Million | CN¥492.14 Million | — |